PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
A 400% utilization spike for a single drug outlier was identified through Artemetrx, allowing the plan to promptly prevent further leakage. The Challenge Miebo is…
Payers can reduce reliance on PBM self-reporting and gain confidence in their guarantee performance. The Challenge Monitoring PBM pricing guarantees across pharmacy networks is complex…
The specialty drug pipeline is accelerating—and the financial implications for plans are significant. With new GLP-1 formulations, MASH therapies, and cell and gene therapy innovations…
How Payer Feedback Can Help Improve the Pharmacy Benefit Management Industry As pharmacy benefit management continues to evolve, the latest findings from the 2025…
For over two decades, hormone replacement therapy (HRT) has been shadowed by cautionary tales and black box warnings. These warnings – rooted in early interpretations…
Avoid Costly Errors with Proactive Pharmacy Benefit Claims Validation Key Points Claims validation helps uncover discrepancies that impact plan performance and member experience. Thorough planning…
Operational Excellence is Essential for Plans and PBMs Key Points The Medicare Transaction Facilitator (MTF), fully operational in 2026, requires plans and PBMs to integrate…
Key Points Value-based care (VBC) challenges the quantity over quality model of healthcare. Technology can enable payers to invest and focus on value-based care for…
Satisfaction with PBMs Hits Historic Lows, Appetite for Change Surges DALLAS, TX – September 23, 2025 – For over two decades, Pharmaceutical Strategies Group (“…
